COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Balance Sheet
USA - NASDAQ:COLL - US19459J1043 - Common Stock
45.98 USD
-0.4 (-0.86%)
45.98 USD
0 (0%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 150.10M | 70.56M | 238.95M | 173.70M | 186.40M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 135.77M | 92.20M | 71.60M | null | null | |||
| Receivables | 233.95M | 228.54M | 179.53M | 183.10M | 105.80M | |||
| Inventories | 38.05M | 35.56M | 32.33M | 46.50M | 17.40M | |||
| Other Current Assets | 56.01M | 55.39M | 15.20M | 16.70M | 5.90M | |||
| Total Current Assets | 613.87M | 482.26M | 537.60M | 420.00M | 315.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.68M | 20.15M | 22.01M | 26.40M | 27.10M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | 145.93M | 162.33M | 133.86M | 133.70M | null | |||
| Intangibles | 724.98M | 891.40M | 421.71M | 567.50M | 268.70M | |||
| Other Non-Current Assets | 105.87M | 107.45M | 28.13M | 26.60M | 80.70M | |||
| Total Non-Current Assets | 993.46M | 1.18B | 605.71M | 754.10M | 376.60M | |||
| TOTAL ASSETS | 1.61B | 1.66B | 1.14B | 1.17B | 692.10M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 64.58M | 64.58M | 183.33M | 162.50M | 48.40M | |||
| Accrued Expenses | 355.62M | 396.85M | 258.74M | 263.40M | 223.80M | |||
| Accounts Payable | 7.65M | 3.93M | 8.69M | 3.50M | 4.20M | |||
| Other Current Liabilities | 25.08M | 44.14M | 7.15M | 4.40M | 3.20M | |||
| Total Current Liabilities | 452.93M | 509.51M | 457.92M | 433.70M | 279.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 743.53M | 787.90M | 483.84M | 538.50M | 201.60M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 136.06M | 137.33M | 6.12M | 7.10M | 8.00M | |||
| Total Non-Current Liabilities | 879.59M | 925.24M | 489.96M | 545.60M | 209.50M | |||
| TOTAL LIABILITIES | 1.33B | 1.43B | 947.88M | 979.30M | 489.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -118.09M | -164.00M | -233.19M | -281.30M | -256.30M | |||
| Additional Paid In Capital | 615.08M | 590.25M | 565.95M | 538.10M | 502.10M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 41.00K | 40.00K | 38.00K | 0 | 0 | |||
| Treasury Stock | -222.51M | -197.50M | -137.38M | -61.90M | -42.90M | |||
| Other Shareholders' Equity | 292.00K | 55.00K | 14.00K | null | null | |||
| Shares Outstanding | 31.60M | 31.44M | 31.87M | 33.80M | 33.70M | |||
| Tangible Book Value per Share | -18.8634 | -26.2369 | -11.3006 | -14.9822 | -1.9525 | |||
| Total Shareholders' Equity | 274.81M | 228.84M | 195.43M | 194.80M | 202.90M | |||
| TOTAL LIABILITIES AND EQUITY | 1.61B | 1.66B | 1.14B | 1.17B | 692.10M | |||
| Statistics | ||||||||
| Debt/Equity | 2.71 | 3.44 | 2.48 | 2.76 | 0.99 | |||
| Current Ratio | 1.36 | 0.95 | 1.17 | 0.97 | 1.13 | |||
| Return On Assets (ROA) | 3.64% | 4.16% | 4.21% | -2.13% | 10.33% | |||
| Return On Equity (ROE) | 21.27% | 30.23% | 24.64% | -12.83% | 35.24% | |||
| Return On Invested Capital (ROIC) | 9.10% | 9.85% | 17.12% | 6.27% | 4.07% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 12.09% | 11.46% | 31.31% | 8.19% | 7.43% | |||
All data in USD , ROIC based on taxRate of 0.33